19Dec
17Dec
Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium to Accelerate Development of Donor-Independent Platelet Production
Platelet Biogenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and genetically engineered platelet-based therapeutics, announced today it received an award of $2.3 million from the Medical Technology Enterprise Consortium (MTEC) – a 501(c)(3) biomedical technology consortium collaborating with the U.S. Army Medical Research and Development Command (USAMRDC). Read more >>
17Dec
New bill proposes Americans use their 401(k) to repay student loan debt
Republican Senator Rand Paul has introduced a bill that would allow Americans to dip into their 401(k) savings to pay down student loans. FutureFuel.io Founder & CEO Laurel Taylor joins Yahoo Finance's Zack Guzman and Heidi Chung, along with Ruby Media Group President Kristen Ruby, to discuss. Read more >>
17Dec
The 20 Startups to Watch in Boston in 2020
Based on factors like funding, partnerships, awards, technology licenses and more, we've worked to identify the startups that are on the precipice of something big. These companies, we think, will be making major moves to kick off the new Roaring 20s. List includes FutureFuel.io. Read more >>
14Dec
For their holidays, a gift of improved vision
Ballet Austin put on a private showing of the classic ballet for a group of visually impaired Austin-area people who received eSight visual aid glasses for the holidays at the Long Center for the Performing Arts on December 5. Read more >>
11Dec
Myomo Announces Partnership with Hobbs Rehabilitation for U
Myomo®, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has formed a partnership with Hobbs Rehabilitation to provide a range of services to support MyoPro® users in the UK. Read more >>
11Dec
Sharp vision: New glasses help the legally blind see
Jeff Regan was born with underdeveloped optic nerves and had spent most of his life in a blur. Then four years ago, he donned an unwieldy headset made by a Toronto company called eSight. Suddenly, Regan could read a newspaper while eating breakfast and make out the faces of his co-workers from across the room. Read more >>
10Dec
Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it will host a symposium on the endocannabinoid system (“ECS”) and the therapeutic potential of targeting the ECS. Read more >>
10Dec
Targeting Ticks: Cornell-Housed Company Designs New Lyme Disease Test
“Current estimates say that approximately 300,000 people come down with Lyme disease every year, and that’s probably an underestimate,” said Dr. Joel Tabb, president and co-founder of Ionica Sciences in Weill Hall’s McGovern Center at Cornell. Dr. Tabb’s team at Ionica Sciences has developed a new and improved diagnostic test for Lyme disease. Read more >>
07Dec